Skip to content
StockMarketAgent
Sector pending / Miscellaneous Health And Allied Services, Not Elsewhere ClassifiedUpdated 2026-05-10 22:07 UTC

BOM/534422 stock hub

BOM/534422 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

BOM/534422is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
64.8M
Bombay Stock Exchange
Market data

Price

Recent price action with selectable time range.

BOM/534422BOM/534422
Loading chart…
In the news

Latest news · BOM/534422

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/E27.3
P25 n/aP50 n/aP75 n/a
ROEn/a
P25 n/aP50 n/aP75 n/a
ROIC-0.3
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All BOM/534422 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
151
Groups with data
10
Currency
INR
Showing 151 of 151 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
India
Country code
IN
Employees
6
Employees Change
0%
Employees Change Percent
0
Enterprise value
INR 64.1M
Exchange
Bombay Stock Exchange
Financial currency
INR
First seen
2026-05-10
Industry
Miscellaneous Health And Allied Services, Not Elsewhere Classified
Last refreshed
2026-05-10
Market cap
INR 64.8M
Price
INR 6.17
Price currency
INR
Rev Per Employee
657,833.33x
Sic
8090
Symbol
bom/534422
Website
https://www.looksclinic.in

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
3.13%
EV Earnings
31.57x
EV/EBITDA
69.77x
EV/Sales
16.23x
P/B ratio
0.44x
P/E ratio
27.33x
P/S ratio
16.41x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

13
MetricValue
EBIT Margin
-12.64%
EBITDA Margin
23.26%
Gross margin
68.69%
Gross Profit
INR 2.7M
Net Income
INR 2M
Net Income Growth3 Y
178.43%
Pretax Margin
58.3%
Profit Margin
51.41%
Profit Per Employee
INR 338,167
Roa5y
-1.97
Roe5y
-0.39
ROIC
-0.3
Roic5y
-3.02

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

7
MetricValue
Cagr10y
-9.64%
Cagr1y
40.26%
Cagr3y
7.62%
Cagr5y
-7.27%
EPS Growth3 Y
192.5
Revenue Growth3 Y
274.74x
Revenue Growth5 Y
19.11x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

11
MetricValue
Cash
INR 735,000
Equity
INR 148.3M
Interest Coverage
-1.84
Net Cash
INR 735,000
Net Cash By Market Cap
INR 1.13
Net Cash Growth
195.18%
Net Debt EBITDA
INR -0.8
Net Debt Equity
INR -0
Tangible Book Value
INR 148.3M
Tangible Book Value Per Share
INR 23.92
WACC
2.94

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
21.71%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

38
MetricValue
10Y total return
-63.71%
1Y total return
40.23%
200-day SMA
5.84
3Y total return
24.65%
50-day SMA
7.38
50-day SMA vs 200-day SMA
50over200
5Y total return
-31.44%
All Time High
249.7
All Time High Change
-97.53%
All Time High Date
2013-12-05
All Time Low
1.19
All Time Low Change
418.49%
All Time Low Date
2020-10-23
ATR
0.46
Beta
-0.24
Beta1y
0.6
Beta2y
0.48
Ch YTD
11.37
High
6.19
High52
10.52
High52 Date
2026-02-24
High52ch
-41.35%
Low
5.72
Low52
3.57
Low52 Date
2025-12-08
Low52ch
72.83%
Ma50ch
-16.38%
Price vs 200-day SMA
5.58%
RSI
44.61
RSI Monthly
50.63
RSI Weekly
48.6
Sharpe ratio
0.64x
Sortino ratio
1.09
Total Return
21.71%
Tr YTD
11.37
Tr1m
0.82%
Tr1w
1.31%
Tr3m
-1.59%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
INR -499,000
Operating margin
-12.64

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

5
MetricValue
Float
7,797,918%
Shares Insiders
11.27%
Shares Out
10,500,000
Shares Qo Q
29.03%
Shares Yo Y
-21.71%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

49
MetricValue
Average Volume
17,624.95x
Bv Per Share
23.92
Ch10y
-63.71
Ch1m
0.82
Ch1w
1.31
Ch1y
40.23
Ch3m
-1.59
Ch3y
24.65
Ch5y
-31.44
Ch6m
23.15
Change
2.83%
Change From Open
7.87
Close
6
Days Gap
-4.67
Depreciation Amortization
1,417,000
Dollar Volume
61,761.7
Earnings Date
2026-05-26
EBIT
INR -499,000
EBITDA
INR 918,000
EPS
INR 0.23
F Score
1
Fiscal Year End
March
Founded
2,011
Graham Number
11.0237
Graham Upside
78.67
Income Tax
INR 272,000
Is Primary Listing
1
Last Earnings Date
2026-01-28
Last Report Date
2025-12-31
Last Split Date
2015-10-29
Last Split Type
Forward
Lynch Fair Value
INR 5.64
Lynch Upside
-8.53
Ma150
6.19
Ma150ch
-0.31%
Ma20
6.11
Ma20ch
0.92%
Next Earnings Date
2026-05-26
Open
5.72
Position In Range
95.74
Price Date
2026-05-08
Price EBITDA
INR 70.57
Ptbv Ratio
0.44
Relative Volume
0.57x
Revenue
3,947,000x
Tax By Revenue
6.89x
Tax Rate
11.82%
Tr6m
23.15%
Volume
10,010
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does BOM/534422 pay a dividend?

Capital-return profile for this ticker.

Performance

BOM/534422 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+40.2%
S&P 500 1Y: n/a
3Y total return
+24.6%
S&P 500 3Y: n/a
5Y total return
-31.4%
S&P 500 5Y: n/a
10Y total return
-63.7%
S&P 500 10Y: n/a
Ownership

Who owns BOM/534422?

Insider, institutional, and short-interest positioning.

Institutional ownership
n/a
Share of float held by funds and institutions
Insider ownership
+11.3%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-21.7%
Negative means the company is buying back shares.
Technical

BOM/534422 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
44.6
Neutral momentum band
Price vs 200-day MA
+5.6%
50/200-day relationship not available
Beta (5Y)
-0.24
Less volatile than the market
Sharpe ratio
0.64
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About BOM/534422

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bom/534422 stock rating?

bom/534422 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bom/534422 analysis?

The full report lives at /stocks/bom/534422/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bom/534422?

The latest report frames bom/534422 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bom/534422 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.